ArticleJournal of medicinal chemistryPublished
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
34 of 48 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of medicinal chemistry
- Published
- Subject terms
- Humans; Amides; Cysteine Endopeptidases; Glutamine; Protease Inhibitors; Antiviral Agents; Inventions; COVID-19; SARS-CoV-2
- PubMed ID
- 38365209
- Added to directory
- Source checked